NL6602581A - - Google Patents

Info

Publication number
NL6602581A
NL6602581A NL6602581A NL6602581A NL6602581A NL 6602581 A NL6602581 A NL 6602581A NL 6602581 A NL6602581 A NL 6602581A NL 6602581 A NL6602581 A NL 6602581A NL 6602581 A NL6602581 A NL 6602581A
Authority
NL
Netherlands
Application number
NL6602581A
Other versions
NL143925B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6602581A publication Critical patent/NL6602581A/xx
Publication of NL143925B publication Critical patent/NL143925B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/10Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms
    • C07D295/104Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/108Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulphur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
NL666602581A 1965-03-09 1966-02-28 Werkwijze voor het bereiden van een geneesmiddel met analgetische en antihistamine-eigenschappen. NL143925B (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9981/65A GB1097572A (en) 1965-03-09 1965-03-09 Novel piperazines for pharmaceutical use

Publications (2)

Publication Number Publication Date
NL6602581A true NL6602581A (US20100012521A1-20100121-C00001.png) 1966-09-12
NL143925B NL143925B (nl) 1974-11-15

Family

ID=9882344

Family Applications (2)

Application Number Title Priority Date Filing Date
NL143925D NL143925C (US20100012521A1-20100121-C00001.png) 1965-03-09
NL666602581A NL143925B (nl) 1965-03-09 1966-02-28 Werkwijze voor het bereiden van een geneesmiddel met analgetische en antihistamine-eigenschappen.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NL143925D NL143925C (US20100012521A1-20100121-C00001.png) 1965-03-09

Country Status (11)

Country Link
US (1) US3448192A (US20100012521A1-20100121-C00001.png)
BE (1) BE676842A (US20100012521A1-20100121-C00001.png)
CH (1) CH448100A (US20100012521A1-20100121-C00001.png)
DE (1) DE1595984A1 (US20100012521A1-20100121-C00001.png)
DK (1) DK121606B (US20100012521A1-20100121-C00001.png)
ES (1) ES323532A1 (US20100012521A1-20100121-C00001.png)
FR (1) FR5390M (US20100012521A1-20100121-C00001.png)
GB (1) GB1097572A (US20100012521A1-20100121-C00001.png)
IL (1) IL25219A (US20100012521A1-20100121-C00001.png)
NL (2) NL143925B (US20100012521A1-20100121-C00001.png)
SE (1) SE327406B (US20100012521A1-20100121-C00001.png)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) * 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
FR2081557B1 (US20100012521A1-20100121-C00001.png) * 1970-03-02 1973-08-10 Cerm Cent Europ Rech Mauvernay
US3755309A (en) * 1971-07-16 1973-08-28 T Takahashi 2-substituted pyridine derivatives and synthesis thereof
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
FR2543139B1 (fr) * 1983-03-22 1985-08-16 Cerm Cent Europ Rech Mauvernay Derives de (1-alcoxy 2-amino) ethyl pyridine ou pyrazine, leur preparation et leur application en therapeutique
IT1200928B (it) * 1983-07-11 1989-01-27 Malesci Sas Procedimento per la preparazione di 1-piridil-alchil-4-aril piperazine utili per la loro attivita' antiipertensiva,lloro separazione nei relativi antipodi ottici e composti stereoisomeri cosi' ottenuti
CA2858520A1 (en) * 2006-05-18 2007-11-29 Pharmacyclics Inc. Intracellular kinase inhibitors
CN101759665B (zh) * 2008-12-23 2012-03-28 江苏恩华药业股份有限公司 取代苯基哌嗪芳烷醇衍生物及其在制备镇痛药物中的应用
US20160060235A1 (en) * 2013-03-29 2016-03-03 National University Corporation Kumamoto University Therapeutic Agent for Type 2 Diabetes

Also Published As

Publication number Publication date
NL143925B (nl) 1974-11-15
IL25219A (en) 1970-05-21
NL143925C (US20100012521A1-20100121-C00001.png)
SE327406B (US20100012521A1-20100121-C00001.png) 1970-08-24
DE1595984A1 (de) 1970-02-05
BE676842A (US20100012521A1-20100121-C00001.png) 1966-07-18
ES323532A1 (es) 1967-01-01
US3448192A (en) 1969-06-03
DK121606B (da) 1971-11-08
GB1097572A (en) 1968-01-03
CH448100A (fr) 1967-12-15
FR5390M (US20100012521A1-20100121-C00001.png) 1967-09-18

Similar Documents

Publication Publication Date Title
FR1483542A (US20100012521A1-20100121-C00001.png)
JPS429480Y1 (US20100012521A1-20100121-C00001.png)
BE675324A (US20100012521A1-20100121-C00001.png)
JPS433100Y1 (US20100012521A1-20100121-C00001.png)
FI42556B (US20100012521A1-20100121-C00001.png)
JPS5133920Y1 (US20100012521A1-20100121-C00001.png)
JPS4311190Y1 (US20100012521A1-20100121-C00001.png)
BE676285A (US20100012521A1-20100121-C00001.png)
BE676055A (US20100012521A1-20100121-C00001.png)
NL6614839A (US20100012521A1-20100121-C00001.png)
NL6604258A (US20100012521A1-20100121-C00001.png)
NL6602684A (US20100012521A1-20100121-C00001.png)
LU50312A1 (US20100012521A1-20100121-C00001.png)
BE682033A (US20100012521A1-20100121-C00001.png)
BE679853A (US20100012521A1-20100121-C00001.png)
BE677367A (US20100012521A1-20100121-C00001.png)
BE676793A (US20100012521A1-20100121-C00001.png)
BE676769A (US20100012521A1-20100121-C00001.png)
BE676630A (US20100012521A1-20100121-C00001.png)
BE676610A (US20100012521A1-20100121-C00001.png)
BE676600A (US20100012521A1-20100121-C00001.png)
BE676536A (US20100012521A1-20100121-C00001.png)
BE676514A (US20100012521A1-20100121-C00001.png)
BE676401A (US20100012521A1-20100121-C00001.png)
BE676842A (US20100012521A1-20100121-C00001.png)

Legal Events

Date Code Title Description
NL80 Abbreviated name of patent owner mentioned of already nullified patent

Owner name: MAUVERNAY

V4 Discontinued because of reaching the maximum lifetime of a patent